Life Science Access Academy Ltd invites you to their event
About this event
Discover how the UK is transforming Pharmaceutical Access...
In the wake of Brexit, there were concerns that the access environment might deteriorate significantly. Thus far, however, the opposite has been true.
The UK is one of Europe’s largest markets but has long had the unenviable reputation of being “low and slow” for the uptake of new medicines. In recent months, however, the government has introduced ground-breaking measures to expedite access. The regulatory and health technology assessment (HTA) agencies have been working with the NHS to develop innovative approaches to make promising new drugs widely available without delay.
These changes are helping to make the UK one of the most inventive access environments in Europe, with a willingness to explore new ideas in partnership with pharmaceutical companies.
Join Ian Chamberlain and Neil Grubert, a Market Access Specialist, and discover what you can learn from the UK experience.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.
